Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants

Published:2023-04-20 Issue:16 Volume:388 Page:1533-1534
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Muller William J.¹^ORCID,Madhi Shabir A.²^ORCID,Seoane Nuñez Beatriz³,Baca Cots Manuel⁴,Bosheva Miroslava⁵,Dagan Ron⁶^ORCID,Hammitt Laura L.⁷,Llapur Conrado J.⁸,Novoa Jose M.⁹,Saez Llorens Xavier¹⁰,Grenham Amy,Kelly Elizabeth J.,Mankad Vaishali S.¹¹,Shroff Manish¹²,Takas Therese,Leach Amanda,Villafana Tonya

Affiliation:

1. Northwestern University, Chicago, IL

2. University of the Witwatersrand, Johannesburg, South Africa

3. AstraZeneca, Barcelona, Spain

4. Quirónsalud Málaga Hospital, Malaga, Spain

5. St. George Medical University, Plovdiv, Bulgaria

6. Ben-Gurion University of the Negev, Beer-Sheva, Israel

7. Johns Hopkins University, Baltimore, MD

8. Hospital del Niño Jesús, San Miguel de Tucumán, Argentina

9. Hospital Padre Hurtado, Santiago, Chile

10. Cevaxin Research Center, Panama City, Panama

11. AstraZeneca, Durham, NC

12. AstraZeneca, Waltham, MA

Funder

AstraZeneca

Sanofi

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMc2214773

Reference3 articles.

1. Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants

2. Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials

3. Decline of influenza and respiratory syncytial virus detection in facility-based surveillance during the COVID-19 pandemic, South Africa, January to October 2020

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody levels against respiratory syncytial virus fusion protein conformations and lack of association with life-threatening infection in previously healthy infants;Vaccine;2024-11

2. Evaluation of the potential impact and cost-effectiveness of respiratory syncytial virus (RSV) prevention strategies for infants in Argentina;Vaccine;2024-10

3. Parental knowledge and attitudes to infant immunization in the context of RSV: All about confidence?;Vaccine;2024-10

4. Molecular and phenotypic characteristics of respiratory syncytial virus isolates recovered from medically vulnerable children: An exploratory analysis of a phase 2/3 randomized, double-blind, palivizumab-controlled trial of nirsevimab (MEDLEY);Vaccine;2024-10

5. Immunomodulatory markers and therapies for the management of infant respiratory syncytial virus infection;Expert Review of Anti-infective Therapy;2024-09-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3